Discontinuation report CIMETIDINE
| Report ID | 70796 |
| Drug Identification Number | 00487872 |
| Brand name | APO CIMETIDINE TAB 300MG |
| Common or Proper name | CIMETIDINE |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIMETIDINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1000 BTL |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-09-18 |
| Actual discontinuation date | |
| Remaining supply date | 2021-09-18 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-01-02 | English | Compare |
| v2 | 2019-01-02 | French | Compare |
Showing 1 to 2 of 2